Clinical Evaluation of Navigated 3D Ultrasound Multicentre Study
Completed
- Conditions
- Brain Neoplasms
- Registration Number
- NCT00233350
- Lead Sponsor
- Norwegian University of Science and Technology
- Brief Summary
3D ultrasound is a new modality used in image guided neurosurgery. a multicentre study is started for the evaluation of this tool as a means for achieving total resection of brain tumors at greater safety.
- Detailed Description
The degree of resection as judged by the surgeon is recorded at the end of surgery for each patient, and then compared with the postoperative MRI. Neurological status before and after surgery, QOL before surgery and at follow-up as well as survival is recorded.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 142
Inclusion Criteria
- Supratentorial glioma
Exclusion Criteria
- Not willing to participate in study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of 3D ultrasound in brain tumor resection as studied in NCT00233350?
How does navigated 3D ultrasound compare to standard MRI-guided neurosurgery in brain tumor resection outcomes?
What biomarkers correlate with improved neurological outcomes in navigated 3D ultrasound brain tumor surgery?
What are the potential adverse events associated with intraoperative 3D ultrasound navigation in neurosurgical procedures?
Are there combination approaches involving navigated 3D ultrasound and molecular therapies for glioblastoma multiforme?
Trial Locations
- Locations (1)
St Olavs Hospital
🇳🇴Trondheim, Norway
St Olavs Hospital🇳🇴Trondheim, Norway